Effect of renin inhibition on adipokines in diabetic rats.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Pakistan Journal of Pharmaceutical Sciences

• Publication date

  2014-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 25015438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome

  2011influential reference
• The metabolic syndrome--from insulin resistance to obesity and diabetes.

  2011cited by this paper
• Standards of Medical Care in Diabetes—2012

  2011cited by this paper
• Angiotensin II-Mediated Microvascular Thrombosis

  2010cited by this paper
• Renin Inhibitor Aliskiren Improves Impaired Nitric Oxide Bioavailability and Protects Against Atherosclerotic Changes

  2008cited by this paper
• The metabolic syndrome--from insulin resistance to obesity and diabetes.

  2008cited by this paper
• Adiponectin: an update.

  2008cited by this paper
• Fatty Acid Oxidation and Insulin Action

  2008cited by this paper
• The metabolic syndrome.

  2008cited by this paper
• Adiponectin and insulin sensitivity in primary aldosteronism.

  2007cited by this paper
• The role of oxidative stress in diabetic complications

  2007cited by this paper
• The burden of diabetes and its complications: trends and implications for intervention.

  2007cited by this paper
• Standards of Medical Care in Diabetes: Response to Power

  2006cited by this paper
• Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.

  2006cited by this paper
• The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity

  2006cited by this paper
• Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase.

  2006cited by this paper
• Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.

  2006cited by this paper
• Standards of medical care in diabetes--2006.

  2006cited by this paper
• Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?

  2005cited by this paper
• Metabolic syndrome.

  2005cited by this paper
• Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.

  2005cited by this paper
• Adiponectin and adiponectin receptors.

  2005cited by this paper
• Adiponectin: a relevant player in PPARγ-agonist-mediated improvements in hepatic insulin sensitivity?

  2005cited by this paper
• Inflamed fat: what starts the fire?

  2005cited by this paper
• Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats

  2005cited by this paper
• Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms.

  2004influential reference
• Identification of Telmisartan as a Unique Angiotensin II: Receptor Antagonist With Selective PPARγ–Modulating Activity

  2004cited by this paper
• [Inflammation and diabetes].

  2004cited by this paper
• The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications.

  2004cited by this paper
• Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

  2003cited by this paper
• Obesity-induced inflammatory changes in adipose tissue.

  2003cited by this paper
• The metabolic syndrome.

  2003cited by this paper
• Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease.

  2003cited by this paper
• Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation.

  2003cited by this paper
• Changes of endothelin in streptozotocin-induced diabetic rats: effects of an angiotensin converting enzyme inhibitor, enalapril maleate.

  2002cited by this paper
• Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats

  2001cited by this paper
• Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.

  2001cited by this paper
• A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.

  2000cited by this paper
• Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

  1993cited by this paper
• Low-dose streptozotocin-induced diabetes in the spontaneously hypertensive rat.

  1991influential reference
• Malondialdehyde determination as index of lipid peroxidation.

  1990cited by this paper
• Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes.

  1989cited by this paper
• Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide.

  1982cited by this paper
• [Serum triglycerides].

  1980cited by this paper
• Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

  1979cited by this paper
• Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.

  1979cited by this paper
• The estimation of red cell superoxide dismutase activity.

  1975cited by this paper
• Enzymatic determination of total serum cholesterol.

  1974cited by this paper
• Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum.

  1973cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen.

  1972cited by this paper
• An improved colour reagent for the determination of blood glucose by the oxidase system.

  1972cited by this paper

• Aliskiren - A promising antioxidant agent beyond hypertension reduction.

  2020cites this paper
• Fiend and friend in the renin angiotensin system: An insight on acute kidney injury.

  2019cites this paper
• Comparison of serum levels of IL-6, IL-8, TGF-β and TNF-α in coronary artery diseases, stable angina and participants with normal coronary artery.

  2018cites this paper
• A Study to Assess the Therapeutic Effect of Enalapril on Olanzapine Induced Metabolic Syndrome in Wistar Rats.

  2017cites this paper
• Comparing six antihypertensive medication classes for preventing new‐onset diabetes mellitus among hypertensive patients: a network meta‐analysis

  2017cites this paper
• Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease.

  2016cites this paper
• The Role of RAAS Inhibition by Aliskiren on Paracetamol‐Induced Hepatotoxicity Model in Rats

  2016cites this paper
• Regulación de la viabilidad y el metabolismo cardiomiocitario por fármacos (aliskiren) y hormonas (chemerina) con capacidad de modular procesos inflamatorios

  2016cites this paper
• Comparative effects of Aliskiren and Telmisartan in high fructose diet-induced metabolic syndrome in rats.

  2015cites this paper